| 臺大學術典藏 |
2021-01-05T00:56:24Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
Kao J.-H.; Chen C.-L.; Chen D.-S.; Chen P.-J.; SHANG-JU WU; Yang H.-C.; Liu C.-H.; Chou S.-W.; Tseng T.-C.; Su T.-H.; Liu C.-J. |
| 臺大學術典藏 |
2020-12-29T06:37:44Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Hung C.-C.; SZU-MIN HSIEH; Liu C.-J.; Liu C.-H.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-12-29T05:33:52Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Yang S.-S.; Liu C.-H.; Huang Y.-J.; Liu C.-H.;Huang Y.-J.;Yang S.-S.;Chang C.-H.;Yang S.-S.;Hsin-Yun Sun;Liu C.-J.;Liu W.-C.;Su T.-H.;Yang H.-C.;Hong C.-M.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Kao J.-H.; Hung C.-C.; Chen D.-S.; Chang C.-H.; Yang S.-S.; HSIN-YUN SUN; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-12-29T05:33:43Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Chen D.-S.; Tseng T.-C.; Chen P.-J.; HSIN-YUN SUN; Su T.-H.; Hsieh S.-M.; Hung C.-C.; Liu C.-J.; Liu C.-H.; Kao J.-H. |
| 臺大學術典藏 |
2020-12-29T05:33:07Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Liu C.-H.;Hsin-Yun Sun;Liu C.-J.;Sheng W.-H.;Hsieh S.-M.;Lo Y.-C.;Liu W.-C.;Su T.-H.;Yang H.-C.;Hong C.-M.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Hung C.-C.;Kao J.-H.; Hung C.-C.; Chen D.-S.; Chen P.-J.; Tseng T.-C.; Hong C.-M.; Yang H.-C.; Su T.-H.; Liu C.-H.; HSIN-YUN SUN; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Kao J.-H. |
| 臺大學術典藏 |
2020-12-18T08:39:40Z |
Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease
|
Tseng T.-C.;Liaw S.-J.;Hsiao C.-H.;Wang C.-Y.;Lee L.-N.;Huang T.-S.;Po-Ren Hsueh; Tseng T.-C.; Liaw S.-J.; Hsiao C.-H.; Wang C.-Y.; Lee L.-N.; Huang T.-S.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-11-03T08:19:42Z |
Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals
|
Kao J.-H.; Chen D.-S.; Tseng T.-C.; Chen P.-J.; Su T.-H.; Liu C.-J.; Lin J.-W.; Lee M.-H.; CHEN-HUA LIU |
| 臺大學術典藏 |
2020-11-03T08:19:42Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
CHEN-HUA LIU; Liu C.-J.; Hung C.-C.; Hsieh S.-M.; Su T.-H.; Sun H.-Y.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-11-03T08:19:41Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Kao J.-H.; Chen D.-S.; Chen P.-J.; Tseng T.-C.; Su T.-H.; Liu C.-J.; CHEN-HUA LIU; Yang S.-S.; Peng C.-Y.; Lin W.-T. |
| 臺大學術典藏 |
2020-11-03T08:19:41Z |
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis
|
Chen C.-L.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.; Yang W.-T.; Tsai C.-H.; Su T.-H.; Chang C.T.; Tseng T.-C.; Liu C.-J. |
| 臺大學術典藏 |
2020-11-03T08:19:40Z |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
|
Chang W.-Y.; Chiu Y.-C.; Chiu F.-W.; Hsu Y.-C.; Tseng T.-C.; Cheng P.-N.; Yang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHEN-HUA LIU; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-11-03T08:19:40Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; CHEN-HUA LIU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H. |
| 臺大學術典藏 |
2020-11-02T02:04:12Z |
Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B
|
Tseng C.-H.; Hsu Y.-C.; Chang C.-Y.; Tseng T.-C.; MING-SHIANG WU; Lin J.-T.; Kao J.-H. |
| 臺大學術典藏 |
2020-09-30T03:22:24Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H.; Hsieh S.-M.; Sheng W.-H.; Liu C.-H.; Sun H.-Y.; Liu C.-J. |
| 臺大學術典藏 |
2020-09-30T03:22:22Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2020-09-30T03:22:14Z |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
|
Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-H.;Liu C.-J.;Chien-Ching Hung;Hsieh S.-M.;Su T.-H.;Sun H.-Y.;Tseng T.-C.;Chen P.-J.;Chen D.-S.;Kao J.-H.; Liu C.-H.; Liu C.-J.; CHIEN-CHING HUNG; Hsieh S.-M.; Su T.-H.; Sun H.-Y. |
| 臺大學術典藏 |
2020-07-01T08:45:20Z |
Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease
|
Tseng T.-C.;Shwu-Jen Liaw;Hsiao C.-H.;Wang C.-Y.;Lee L.-N.;Huang T.-S.;Hsueh P.-R.; Tseng T.-C.; SHWU-JEN LIAW; Hsiao C.-H.; Wang C.-Y.; Lee L.-N.; Huang T.-S.; Hsueh P.-R. |
| 臺大學術典藏 |
2020-07-01T08:12:15Z |
Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1
|
Tseng T.-C.;Huang D.-Y.;Liang-Chuan Lai;Hwai H.;Hsiao Y.-W.;Jhou J.-P.;Chuang E.Y.;Tzeng S.-J.; Tseng T.-C.; Huang D.-Y.; LIANG-CHUAN LAI; Hwai H.; Hsiao Y.-W.; Jhou J.-P.; Chuang E.Y.; Tzeng S.-J. |
| 臺大學術典藏 |
2020-06-19T02:27:03Z |
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
|
Su T.-H.;Shiau C.-W.;Jao P.;Yang N.-J.;Tai W.-T.;Liu C.-J.;Tseng T.-C.;Yang H.-C.;Liu C.-H.;Kai-Wen Huang;Hu T.-C.;Huang Y.-J.;Wu Y.-M.;Chen L.-J.;Chen P.-J.;Chen D.-S.;Chen K.-F.;Kao J.-H.; Su T.-H.; Shiau C.-W.; Jao P.; Yang N.-J.; Tai W.-T.; Liu C.-J.; Tseng T.-C.; Yang H.-C.; Liu C.-H.; KAI-WEN HUANG; Hu T.-C.; Huang Y.-J.; Wu Y.-M.; Chen L.-J.; Chen P.-J.; Chen D.-S.; Chen K.-F.; Kao J.-H. |
| 臺大學術典藏 |
2020-06-19T02:27:01Z |
Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy
|
Su T.-H.;Liao C.-H.;Liu C.-H.;Kai-Wen Huang;Tseng T.-C.;Yang H.-C.;Liu C.-J.;Chen P.-J.;Chen D.-S.;Kao J.-H.; Su T.-H.; Liao C.-H.; Liu C.-H.; KAI-WEN HUANG; Tseng T.-C.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-06-03T08:10:33Z |
Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease
|
Tseng T.-C.;Liaw S.-J.;Hsiao C.-H.;Wang C.-Y.;Lee L.-N.;Tien-Shang Huang;Hsueh P.-R.; Tseng T.-C.; Liaw S.-J.; Hsiao C.-H.; Wang C.-Y.; Lee L.-N.; TIEN-SHANG HUANG; Hsueh P.-R. |
| 臺大學術典藏 |
2020-04-16T02:34:20Z |
Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via FcγRIIB and HO-1
|
Tseng, T.-C.; Huang, D.-Y.; Lai, L.-C.; Hwai, H.; Hsiao, Y.-W.; Jhou, J.-P.; Chuang, E.Y.; Tzeng, S.-J.; ERIC YAO-YU CHUANG |
| 臺大學術典藏 |
2020-03-27T05:30:44Z |
Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease
|
PO-REN HSUEH;Huang T.-S.;Lee L.-N.;Wang C.-Y.;Hsiao C.-H.;Liaw S.-J.;Tseng T.-C.; Tseng T.-C.; Liaw S.-J.; Hsiao C.-H.; Wang C.-Y.; Lee L.-N.; Huang T.-S.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-06T08:25:07Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
Su T.-H.; Liu C.-J.; Yang H.-C.; YUNG-MING JENG; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:00Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Liu C.-H.; Liu C.-J.; Tai W.-T.; YUNG-MING JENG; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.; Su T.-H.;Shiau C.-W.;Jao P.;Liu C.-H.;Liu C.-J.;Tai W.-T.;Yung-Ming Jeng;Yang H.-C.;Tseng T.-C.;Huang H.-P.;Cheng H.-R.;Chen P.-J.;Chen K.-F.;Kao J.-H.;Chen D.-S.; Su T.-H.; Shiau C.-W.; Jao P. |
